Kalvista Pharmaceuticals Stock Price History
KALV Stock | USD 9.32 0.36 4.02% |
Below is the normalized historical share price chart for Kalvista Pharmaceuticals extending back to April 09, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Kalvista Pharmaceuticals stands at 9.32, as last reported on the 21st of November, with the highest price reaching 9.33 and the lowest price hitting 8.75 during the day.
If you're considering investing in Kalvista Stock, it is important to understand the factors that can impact its price. Kalvista Pharmaceuticals has Sharpe Ratio of -0.0783, which conveys that the firm had a -0.0783% return per unit of risk over the last 3 months. Kalvista Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kalvista Pharmaceuticals' Standard Deviation of 4.62, mean deviation of 3.22, and Risk Adjusted Performance of (0.06) to check out the risk estimate we provide.
At this time, Kalvista Pharmaceuticals' Common Stock Shares Outstanding is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to climb to about 247.2 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 18.1 K in 2024. . Price Earnings To Growth Ratio is likely to climb to 0.59 in 2024, whereas Price To Sales Ratio is likely to drop 46.33 in 2024. Kalvista Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of April 2015 | 200 Day MA 12.207 | 50 Day MA 11.0974 | Beta 0.913 |
Kalvista |
Sharpe Ratio = -0.0783
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | KALV |
Estimated Market Risk
4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
-0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kalvista Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kalvista Pharmaceuticals by adding Kalvista Pharmaceuticals to a well-diversified portfolio.
Price Book 2.5519 | Enterprise Value Ebitda (3.53) | Price Sales 107.4168 | Shares Float 24.9 M | Wall Street Target Price 29.1667 |
Kalvista Pharmaceuticals Stock Price History Chart
There are several ways to analyze Kalvista Stock price data. The simplest method is using a basic Kalvista candlestick price chart, which shows Kalvista Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | August 30, 2024 | 13.39 |
Lowest Price | November 20, 2024 | 8.96 |
Kalvista Pharmaceuticals November 21, 2024 Stock Price Synopsis
Various analyses of Kalvista Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Kalvista Stock. It can be used to describe the percentage change in the price of Kalvista Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Kalvista Stock.Kalvista Pharmaceuticals Price Rate Of Daily Change | 1.04 | |
Kalvista Pharmaceuticals Accumulation Distribution | 30,665 | |
Kalvista Pharmaceuticals Price Daily Balance Of Power | 0.62 | |
Kalvista Pharmaceuticals Price Action Indicator | 0.46 |
Kalvista Pharmaceuticals November 21, 2024 Stock Price Analysis
Kalvista Stock Price History Data
The price series of Kalvista Pharmaceuticals for the period between Fri, Aug 23, 2024 and Thu, Nov 21, 2024 has a statistical range of 4.43 with a coefficient of variation of 9.34. The daily prices for the period are spread out with arithmetic mean of 11.4. The median price for the last 90 days is 11.41. The company underwent 1:14 stock split on 22nd of November 2016. Kalvista Pharmaceuticals issued dividends to stockholders on 2016-11-22.Open | High | Low | Close | Volume | ||
11/21/2024 | 9.02 | 9.33 | 8.75 | 9.32 | 493,279 | |
11/20/2024 | 9.00 | 9.40 | 8.90 | 8.96 | 419,335 | |
11/19/2024 | 9.22 | 9.40 | 8.94 | 9.05 | 479,686 | |
11/18/2024 | 9.49 | 9.57 | 8.75 | 9.30 | 905,686 | |
11/15/2024 | 9.96 | 9.96 | 9.34 | 9.49 | 816,274 | |
11/14/2024 | 10.47 | 10.49 | 9.75 | 9.80 | 521,825 | |
11/13/2024 | 10.75 | 10.97 | 10.44 | 10.45 | 314,179 | |
11/12/2024 | 11.11 | 11.22 | 10.58 | 10.67 | 394,175 | |
11/11/2024 | 11.38 | 11.62 | 10.88 | 11.09 | 468,257 | |
11/08/2024 | 11.18 | 11.41 | 10.94 | 11.41 | 339,032 | |
11/07/2024 | 11.35 | 11.58 | 11.02 | 11.18 | 227,064 | |
11/06/2024 | 12.00 | 12.12 | 11.21 | 11.41 | 426,208 | |
11/05/2024 | 11.45 | 11.68 | 10.78 | 11.25 | 622,681 | |
11/04/2024 | 11.30 | 12.85 | 10.92 | 11.63 | 755,375 | |
11/01/2024 | 10.29 | 10.72 | 10.22 | 10.61 | 281,259 | |
10/31/2024 | 11.16 | 11.42 | 10.01 | 10.27 | 493,166 | |
10/30/2024 | 11.66 | 11.81 | 11.17 | 11.20 | 88,572 | |
10/29/2024 | 12.05 | 12.15 | 11.63 | 11.79 | 92,000 | |
10/28/2024 | 11.77 | 12.34 | 11.77 | 12.09 | 107,762 | |
10/25/2024 | 12.16 | 12.23 | 11.68 | 11.68 | 119,130 | |
10/24/2024 | 12.01 | 12.14 | 11.77 | 12.07 | 300,324 | |
10/23/2024 | 12.34 | 12.42 | 11.83 | 12.01 | 199,168 | |
10/22/2024 | 12.25 | 12.40 | 12.05 | 12.35 | 98,370 | |
10/21/2024 | 12.48 | 12.50 | 12.17 | 12.32 | 107,905 | |
10/18/2024 | 12.16 | 12.52 | 12.10 | 12.50 | 119,396 | |
10/17/2024 | 12.31 | 12.31 | 11.98 | 12.09 | 127,877 | |
10/16/2024 | 12.10 | 12.50 | 11.93 | 12.33 | 251,766 | |
10/15/2024 | 11.72 | 12.03 | 11.47 | 11.98 | 176,548 | |
10/14/2024 | 11.58 | 11.75 | 11.45 | 11.72 | 129,909 | |
10/11/2024 | 10.95 | 11.67 | 10.95 | 11.63 | 194,049 | |
10/10/2024 | 11.15 | 11.20 | 10.84 | 10.99 | 257,825 | |
10/09/2024 | 11.20 | 11.41 | 11.02 | 11.24 | 310,928 | |
10/08/2024 | 11.37 | 11.58 | 11.11 | 11.21 | 265,654 | |
10/07/2024 | 11.27 | 11.37 | 11.11 | 11.28 | 210,817 | |
10/04/2024 | 11.61 | 11.82 | 11.14 | 11.36 | 448,251 | |
10/03/2024 | 11.75 | 11.98 | 11.54 | 11.54 | 182,964 | |
10/02/2024 | 11.30 | 11.86 | 11.27 | 11.84 | 564,249 | |
10/01/2024 | 11.43 | 11.56 | 10.93 | 11.39 | 1,095,176 | |
09/30/2024 | 12.24 | 12.55 | 11.44 | 11.58 | 693,203 | |
09/27/2024 | 10.50 | 12.36 | 10.26 | 12.34 | 1,828,014 | |
09/26/2024 | 9.65 | 10.03 | 9.48 | 10.00 | 394,886 | |
09/25/2024 | 9.72 | 9.83 | 9.45 | 9.46 | 201,884 | |
09/24/2024 | 9.78 | 9.96 | 9.62 | 9.65 | 247,374 | |
09/23/2024 | 10.57 | 10.57 | 9.78 | 9.78 | 264,156 | |
09/20/2024 | 10.98 | 10.99 | 10.39 | 10.49 | 2,075,017 | |
09/19/2024 | 10.94 | 11.23 | 10.76 | 11.00 | 272,047 | |
09/18/2024 | 10.56 | 10.99 | 10.55 | 10.69 | 249,368 | |
09/17/2024 | 10.83 | 11.13 | 10.46 | 10.57 | 763,330 | |
09/16/2024 | 11.20 | 11.25 | 10.52 | 10.77 | 395,322 | |
09/13/2024 | 10.59 | 11.26 | 10.40 | 11.14 | 427,764 | |
09/12/2024 | 10.73 | 10.89 | 10.44 | 10.46 | 554,901 | |
09/11/2024 | 11.08 | 11.42 | 10.65 | 10.72 | 319,181 | |
09/10/2024 | 11.85 | 12.00 | 11.19 | 11.21 | 556,002 | |
09/09/2024 | 12.19 | 12.81 | 11.72 | 11.87 | 350,859 | |
09/06/2024 | 13.14 | 13.14 | 12.23 | 12.34 | 234,664 | |
09/05/2024 | 13.10 | 13.10 | 12.60 | 12.87 | 223,263 | |
09/04/2024 | 12.27 | 13.03 | 12.26 | 12.92 | 197,177 | |
09/03/2024 | 13.37 | 13.52 | 12.14 | 12.37 | 252,454 | |
08/30/2024 | 13.09 | 13.47 | 12.68 | 13.39 | 725,197 | |
08/29/2024 | 13.02 | 13.33 | 12.86 | 13.00 | 189,266 | |
08/28/2024 | 12.62 | 13.05 | 12.53 | 12.89 | 214,414 |
About Kalvista Pharmaceuticals Stock history
Kalvista Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kalvista is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kalvista Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kalvista Pharmaceuticals stock prices may prove useful in developing a viable investing in Kalvista Pharmaceuticals
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 36.8 M | 38.6 M | |
Net Loss | -24.8 M | -26.1 M |
Kalvista Pharmaceuticals Quarterly Net Working Capital |
|
Kalvista Pharmaceuticals Stock Technical Analysis
Kalvista Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
All Next | Launch Module |
Kalvista Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Kalvista Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Kalvista Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kalvista to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.57) | |||
Total Risk Alpha | (0.94) | |||
Treynor Ratio | (0.23) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.